Aliment Pharmacol Ther

1. YOON JS, Hong JH, Park SY, Kim SU, et al
   High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study.
   Aliment Pharmacol Ther. 2024 Feb 22. doi: 10.1111/apt.17909.
   

   >> Share

   
   

   
   Am J Gastroenterol

2. DU RC, Lu NH, Hu Y
   Is 10-Day Vonoprazan With High-Dose Amoxicillin Dual Therapy Efficient for Eradicating Helicobacter pylori Infection in China?
   Am J Gastroenterol. 2024 Feb 19. doi: 10.14309/ajg.0000000000002641.
   

   >> Share

   
   

   
   Gastroenterology

3. SUN D, Mulder DT, Li Y, Nieboer D, et al
   The Effect of Nationwide Organized Cancer Screening Programs on Gastric Cancer Mortality: a Synthetic Control Study.
   Gastroenterology. 2023 Nov 23:S0016-5085(23)05562.
   

   >> Share

   
   

   
   Helicobacter

4. MARZHOSEYNI Z, Mousavi MJ, Ghotloo S
   Helicobacter pylori antigens as immunomodulators of immune system.
   Helicobacter. 2024;29:e13058.
   

   >> Share

   
   

   
   J Clin Gastroenterol

5. AL KHOURY A, Taheri Tanjani M, Hari B, Almadi MA, et al
   Primary and Specialty Care Trainees' Perceptions About Proton Pump Inhibitor Use.
   J Clin Gastroenterol. 2024 Feb 19. doi: 10.1097/MCG.0000000000001983.
   

   >> Share

   
   

   
   J Gastroenterol Hepatol

6. KIM NH, Chang Y, Ryu S, Sohn CI, et al
   Impact of metabolic unhealthiness and its changes on the risk of erosive esophagitis: a cohort study.
   J Gastroenterol Hepatol. 2024 Feb 21. doi: 10.1111/jgh.16519.
   

   >> Share

   
   

   
   Surg Endosc

7. LI B, Wang Y, Wu Z, Shan F, et al
   Safety and short-term outcomes of a modified valvuloplastic esophagogastrostomy versus gastric tube anastomosis after laparoscopy-assisted proximal gastrectomy: a retrospective cohort study.
   Surg Endosc. 2024;38:1523-1532.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share